Why the Bod (ASX:BDA) share price is climbing today

This ASX cannabis stock is on the rise today after a promising sales update

| More on:
women working with medicinal marijuana, indicating a share price movement in ASX cannabis shares

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Bod Australia Ltd (ASX: BDA) share price is a strong performer today following the release of a sales update.

At the time of writing, shares in the CBD and hemp healthcare products company are up 3% to 35 cents.

What's driving the Bod share price higher?

According to its latest update, Bod enjoyed record medicinal cannabis sales growth in FY21.

In total, Bod dispensed 12,187 products, representing a 212% increase on the prior corresponding period.

The company also delivered a 17% quarter-on-quarter growth, with 4,441 medicinal cannabis product units sold in the fourth quarter of FY21.

In addition, it retained a 46% share of the total Australian market for full plant high CBD products in FY21. Pleasingly, its market share continues to gather pace, increasing in the last six months of FY21.

In further news, the company said its strong and growing market share was underpinned by repeat prescriptions. These accounted for 65% of total prescriptions sold in FY21.

Additionally, Bod's ongoing educational initiatives with healthcare professionals and an Australia-wide study into the effectiveness of its medicinal cannabis range also contributed to its growth.

Looking ahead, the company intends to scale up operations across its Australian and United Kingdom markets to drive growth and market share.

How that affects the Bod share price remains to be seen.

Management commentary

Bod CEO Jo Patterson was pleased with the company's growth momentum, saying:

During FY2021, the company maintained nearly a 50% market share for the total addressable market for high CBD products in Australia. While repeat prescriptions remained at a high level, Bod also increased its patient and doctor acquisitions through ongoing educational initiatives and its relationships with approved prescribers.

We anticipate increased demand for our medicinal cannabis product suite over the coming quarter and beyond. A number of new products are currently being introduced and operations in the UK continue to scale pleasingly. We look forward to updating shareholders on further growth as it materialises.

Bod share price tumbles in 2021

Despite the company's positive achievements in FY21, the Bod share price has tumbled 28% year-to-date.

However, the broader ASX cannabis sector has also struggled to find headway in the past few months.

Bod peers including Cann Group Ltd (ASX: CAN), Ecofibre Ltd (ASX: EOF) and Althea Group Holdings Ltd (ASX: AGH) have tumbled 38%, 63%, and 25% respectively, year-to-date.

Motley Fool contributor Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Broker Notes

These ASX 200 shares could rise 50% to 60%

Brokers believe these shares could deliver big returns for investors.

Read more »

A girl is handed an oversized ice cream cone with lots of different flavours.
Best Shares

8 ASX All Ords shares that tripled in value in FY25

Just 8 out of the 500 companies making up the ASX All Ords achieved share price growth of 200% or…

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Woman with a scared look has hands on her face.
Broker Notes

Bapcor shares fell more than 30% yesterday. Should investors buy in the dip?

Is this a value opportunity?

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Broker Notes

Broker raises price targets on 2 ASX 200 shares to buy

Ord Minnett has just upped its 12-month share price targets on 2 buy-rated ASX 200 stocks.

Read more »

Man with rocket wings which have flames coming out of them.
Share Gainers

Guess which ASX All Ords stock just rocketed 34% on strong earnings growth

Investors just sent this ASX All Ords stock surging 34%. Here’s what’s happening.

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why DroneShield, Gentrack, Metals X, and Northern Star shares are tumbling today

These shares are ending the week in the red. But why?

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Share Gainers

Why Dimerix, Newmont, Regal Partners, and Titomic shares are storming higher

These shares are having a good finish to the week. Let's see why.

Read more »